Global Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Forecast 2024-2030- Product Image

Sale

Global Urokinase Market by Type (Urokinase Powder, Urokinase Solution), Dose Strength (250000 Unit, 5000 Unit), Indication, Application - Forecast 2024-2030

Report
189 Pages
March 2024
Region: Global
360iResearch™
ID: 4995126

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Urokinase Market size was estimated at USD 2.57 billion in 2023, USD 2.68 billion in 2024, and is expected to grow at a CAGR of 4.47% to reach USD 3.49 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Urokinase Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Urokinase Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Urokinase Market, highlighting leading vendors and their innovative profiles. These include BioVision, Inc., Eumedica Pharmaceuticals, JCR Pharmaceuticals Co., Ltd., Jiangxi Haoran Bio-Pharma, Jigs chemical, Kraeber & Co GmbH, Merck KGaA, Microbix Biosystems Inc., Midas Pharma GmbH, Salvavidas Pharmaceutical Pvt. Ltd., Syner-Med Pharmaceuticals, and Taj Pharmaceuticals Ltd.

Market Segmentation & Coverage

This research report categorizes the Urokinase Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Urokinase Powder
- Urokinase Solution
Dose Strength
- 250000 Unit
- 5000 Unit
Indication
- Obstruction
- Pulmonary Embolism
- Thromboembolism of the Coronary Artery
- Thromboembolism of the Graft
- Thromboembolism of the Peripheral Artery
Application
- Clinic
- Hospital

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Urokinase Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Urokinase Market?
What are the technology trends and regulatory frameworks in the Urokinase Market?
What is the market share of the leading vendors in the Urokinase Market?
Which modes and strategic moves are suitable for entering the Urokinase Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Urokinase Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of pulmonary embolism globally
5.1.1.2. Usage of urokinase in the treatment of cardiovascular disease
5.1.1.3. Growing instances of Intracerebral hemorrhage
5.1.2. Restraints
5.1.2.1. Side effects caused by urokinase such as Urticaria, difficulty in breathing, and swelling of face, lips, tongue, or throat
5.1.3. Opportunities
5.1.3.1. Ongoing research activities for using urokinase in stroke patients
5.1.3.2. Economic development and substantial infrastructure development
5.1.4. Challenges
5.1.4.1. Urokinase is contraindicated in patients suffering from cancer, brain tumor and high blood pressure
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Urokinase Market, by Type

6.1. Introduction
6.2. Urokinase Powder
6.3. Urokinase Solution

7. Urokinase Market, by Dose Strength

7.1. Introduction
7.2. 250000 Unit
7.3. 5000 Unit

8. Urokinase Market, by Indication

8.1. Introduction
8.2. Obstruction
8.3. Pulmonary Embolism
8.4. Thromboembolism of the Coronary Artery
8.5. Thromboembolism of the Graft
8.6. Thromboembolism of the Peripheral Artery

9. Urokinase Market, by Application

9.1. Introduction
9.2. Clinic
9.3. Hospital

10. Americas Urokinase Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Urokinase Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Urokinase Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. BioVision, Inc.
14.1.2. Eumedica Pharmaceuticals
14.1.3. JCR Pharmaceuticals Co., Ltd.
14.1.4. Jiangxi Haoran Bio-Pharma
14.1.5. Jigs chemical
14.1.6. Kraeber & Co GmbH
14.1.7. Merck KGaA
14.1.8. Microbix Biosystems Inc.
14.1.9. Midas Pharma GmbH
14.1.10. Salvavidas Pharmaceutical Pvt. Ltd.
14.1.11. Syner-Med Pharmaceuticals
14.1.12. Taj Pharmaceuticals Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. UROKINASE MARKET RESEARCH PROCESS
FIGURE 2. UROKINASE MARKET SIZE, 2023 VS 2030
FIGURE 3. UROKINASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UROKINASE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. UROKINASE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. UROKINASE MARKET DYNAMICS
FIGURE 7. UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. UROKINASE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2030 (%)
FIGURE 10. UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 12. UROKINASE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. UROKINASE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. UROKINASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. UROKINASE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 9. UROKINASE MARKET SIZE, BY 250000 UNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. UROKINASE MARKET SIZE, BY 5000 UNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 12. UROKINASE MARKET SIZE, BY OBSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. UROKINASE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. UROKINASE MARKET SIZE, BY THROMBOEMBOLISM OF THE CORONARY ARTERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. UROKINASE MARKET SIZE, BY THROMBOEMBOLISM OF THE GRAFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. UROKINASE MARKET SIZE, BY THROMBOEMBOLISM OF THE PERIPHERAL ARTERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 18. UROKINASE MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. UROKINASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS UROKINASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. CANADA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 35. CANADA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. MEXICO UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 39. MEXICO UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES UROKINASE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC UROKINASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. CHINA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. CHINA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 57. CHINA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. INDIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. INDIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 61. INDIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. JAPAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 69. JAPAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. THAILAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 93. THAILAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 104. DENMARK UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. DENMARK UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 106. DENMARK UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. DENMARK UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EGYPT UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. EGYPT UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 110. EGYPT UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. EGYPT UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. FINLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. FINLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 114. FINLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. FINLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 118. FRANCE UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 122. GERMANY UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. ITALY UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. ITALY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 130. ITALY UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NORWAY UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. NORWAY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 142. NORWAY UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. NORWAY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. POLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. POLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 146. POLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. POLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. QATAR UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. QATAR UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 150. QATAR UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 166. SPAIN UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 167. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. TURKEY UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 178. TURKEY UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. TURKEY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM UROKINASE MARKET SIZE, BY DOSE STRENGTH, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM UROKINASE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. UROKINASE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 189. UROKINASE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 190. UROKINASE MARKET LICENSE & PRICING

Companies Mentioned

BioVision, Inc.
Eumedica Pharmaceuticals
JCR Pharmaceuticals Co., Ltd.
Jiangxi Haoran Bio-Pharma
Jigs chemical
Kraeber & Co GmbH
Merck KGaA
Microbix Biosystems Inc.
Midas Pharma GmbH
Salvavidas Pharmaceutical Pvt. Ltd.
Syner-Med Pharmaceuticals
Taj Pharmaceuticals Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 2.68 Billion
Forecasted Market Value ( USD ) by 2030	$ 3.49 Billion
Compound Annual Growth Rate	4.4%
Regions Covered	Global
No. of Companies Mentioned	12

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Urokinase Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And Anticoagulants Type, By Application, By Region, And Segment Forecasts, 2023 - 2030

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2023-2028

Global Anti-Ischemic Agents Market by Type (Antiplatelet Agents, Calcium Channel Blockers, Organic Nitrates), Indication (Angina Pectoris, Ischemic Stroke, Myocardial Infarction), Route of Administration, End-User - Forecast 2024-2030

Global Anti-vascular Endothelial Growth Factor Therapeutics Market by Therapeutic Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors), Route of Administration (Intravitreal Injections, Oral Administration), Indication - Forecast 2024-2030

About the Urokinase Market